WTA
DXCM icon

Washington Trust Advisors’s DexCom DXCM Stock Holding History

Washington Trust Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-353
Closed -$43.8K – 664
2023
Q4 		$43.8K Buy
353
+193
+121% +$19.7K ﹤0.01% 327
2023
Q3 		$14.9K Buy
+160
New +$18K ﹤0.01% 418
2023
Q2 		– Sell
-204
Closed -$23.7K – 692
2023
Q1 		$23.7K Sell
204
-24
-11% -$2.69K ﹤0.01% 394
2022
Q4 		$25.8K Hold
228
– – ﹤0.01% 387
2022
Q3 		$18K Hold
228
– – ﹤0.01% 531
2022
Q2 		$17K Buy
228
+48
+27% +$4.38K ﹤0.01% 561
2022
Q1 		$23K Sell
180
-516
-74% -$56.4K ﹤0.01% 582
2021
Q4 		$93K Buy
+696
New +$100K 0.01% 374

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Washington Trust Advisors's DXCM Position: Q1 2024 in Review

Washington Trust Advisors sold out of DexCom (DXCM) in Q1 2024, closing a stake of 353 shares — an estimated $43.8K sold.

Washington Trust Advisors first reported a position in DXCM in Q4 2021 and held it in 8 quarters. The position peaked at $93K in Q4 2021. 1,032 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

  • Washington Trust Advisors reported no remaining DexCom position as of Q1 2024 after selling out during the quarter.
  • Washington Trust Advisors sold 353 DexCom shares in Q1 2024, an estimated $43.8K.
  • Washington Trust Advisors first reported a position in DexCom in Q4 2021 and held it in 8 quarters.
  • Washington Trust Advisors's DexCom position peaked at $93K in Q4 2021.
  • 1,032 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on Washington Trust Advisors's 13F filing for Q1 2024, filed 7 May 2024.